# Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole

> **NCT00205660** · PHASE4 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 51 (actual)

## Conditions studied

- Schizophrenia
- Type 2 Diabetes Mellitus

## Interventions

- **OTHER:** Stayers
- **OTHER:** Switchers

## Key facts

- **NCT ID:** NCT00205660
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2019-01-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00205660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00205660, "Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00205660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*